Work

Why a pomegranate?

Year: 2000
Type: article
Abstract: Objective To examine health professionals9 experiences of and attitudes towards the provision of chemotherapy to patients with end stage cancer. Design Purposive, qualitative design based on in-depth interviews. Setting Oncology departments at university hospitals and general hospitals in the Netherlands. Participants 14 physicians and 13 nurses who cared for patients with metastatic cancer. Results Physicians and nurses reported trying to inform patients fully about their poor prognosis and treatment options. They would carefully consider the (side) effects of chemotherapy and sometimes doubted whether further treatment would contribute to patients9 quality of life. Both groups considered the patients9 wellbeing to be important, and physicians seemed inclined to try to preserve this by offering further chemotherapy, often followed by the patient. Nurses were more often inclined to express their doubts about further treatment, preferring to allow patients to make the best use of the time that is left. When confronted with a treatment dilemma and a patient9s wish for treatment, physicians preferred to make compromises, such as by “trying out one dose.” Discussing death or dying with patients while at the same time administering chemotherapy was considered contradictory as this could diminish the patients9 hope. Conclusions The trend to greater use of chemotherapy at the end of life could be explained by patients9 and physicians9 mutually reinforcing attitudes of “not giving up” and by physicians9 broad interpretation of patients9 quality of life, in which taking away patients9 hope by withholding treatment is considered harmful. To rebalance the ratio of quantity of life to quality of life, input from other health professionals, notably nurses, may be necessary.
Source: BMJ
Author: P. Langley
Language: Hungarian
Field: Medicine
Open Access status: green
OpenAlex ID: W2079332689
FWCI: 1.221
Cites: 8
Cited by: 156
Related to: 10